Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wufuxinnaoqing Soft Capsule for chronic stable angina
ChiCTR-TRC-14005158Phase 4Completed
- Sponsor
- Xiyuan Hospital
- Start
- Mar 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of wufuxinnaoqing in angina pectoris (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Angina symptom score. Started Mar 2012; status: completed.
02
Drugs
wufuxinnaoqing
03
Conditions
angina pectoris
Beyond the preview
Go deeper on ChiCTR-TRC-14005158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005158.